Product Pipeline

This page contains Forward Looking Statements made as of October 19, 2016.*

We are developing product candidates for potential application in several diseases and conditions. Click on a product or development pipeline to learn more.

AIR001

Vepoloxamer

*Forward-Looking Statements: Any statement contained in this page that is not a statement of historical fact should be considered a forward-looking statement that speaks only as the date of the post in which it is made. Forward-looking statements are subject to risks and uncertainties that could cause actual results and events to differ materially from those anticipated, including risks related to the development and commercialization of pharmaceutical products. Please see the Terms and Conditions of Use page of this website for more information about forward-looking statements.